Literature DB >> 1509525

Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.

R Topaloğlu1, U Saatçi, A Bakkaloğlu, N Beşbaş, Y Başsoy.   

Abstract

The levels of protein C (PC) and antithrombin III (AT III) antigens (ag) were measured in the plasma of 39 patients with various histologic types of primary nephrotic syndrome (NS) and in 12 patients with amyloidosis secondary to familial Mediterranean fever (FMF). The controls comprised 15 healthy children. Normal or elevated PC levels were observed in primary NS patients (mean 64%, range 36-98%) and in amyloidosis patients (mean 58%, range 48-70%). There was no difference found between PC ag levels in primary NS and in amyloidosis patients. In addition, no correlation existed between protein selectivity and the PC ag levels in the primary NS patients. Normal and decreased levels of AT III were observed (mean 29 mg/dl, range 11.1-39 mg/dl) in the patients with primary NS and amyloidosis (mean 31 mg/dl range, 21-39 mg/dl). The AT III ag levels of these two groups did not differ and no correlation was found between protein selectivity and AT III levels in primary NS patients. These results suggest that in patients with primary NS, or amyloidosis secondary to FMF, hypercoagulability is not related to a deficiency in PC ag levels due to a dynamic balance between urinary losses, increased rate of hepatic synthesis, catabolism and the distribution of PC in the body compartments. Patients with low AT III levels may be more susceptible to thromboembolic complications than patients with normal levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1509525

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  4 in total

1.  Familial Mediterranean fever and demyelinating plaques in the central nervous system.

Authors:  Metin Işık
Journal:  Eur J Rheumatol       Date:  2014-12-01

2.  Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience.

Authors:  Betul Tavil; Fehime Kara; Rezan Topaloglu; Selin Aytac; Sule Unal; Baris Kuskonmaz; Mualla Cetin; Nesrin Besbas; Fatma Gumruk
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

3.  Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?

Authors:  G Akman-Demir; A Gul; E Gurol; H Ozdogan; S Bahar; A E Oge; H Gurvit; G Saruhan-Direskeneli; H Yazici; M Eraksoy
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

4.  Endovascular pharmacomechanical thrombolysis-a novel treatment for circumaortic left renal vein and inferior vena cava thrombosis in a paediatric patient with relapsing nephrotic syndrome.

Authors:  Manraj Kanwal Singh Heran; Tyler Michael Coupal; Janis Dionne
Journal:  BJR Case Rep       Date:  2017-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.